Cabotres 40 Tablet is an anti-cancer medication utilized in the treatment of renal cell carcinoma. This condition involves the uncontrolled growth of cancer cells in the kidney, leading to tumor formation. Cabotres 40 Tablet is employed as a first-line treatment for advanced renal cell carcinoma, often in conjunction with nivolumab, and is also indicated for hepatocellular carcinoma in patients who have previously undergone treatment with sorafenib.
The active ingredient in Cabotres 40 Tablet is Cabozantinib, which falls under the category of kinase inhibitors. Its mechanism of action involves the inhibition of an enzyme known as tyrosine kinase, thereby halting the abnormal proliferation of cancer cells.
Patients taking Cabotres 40 Tablet may experience side effects including diarrhea, reduced appetite, nausea, vomiting, elevated blood pressure, muscle cramps, weight loss, dizziness, and constipation. It is important to notify your doctor if any of these side effects become troublesome. Cabotres 40 Tablet should be taken strictly as prescribed by your healthcare provider.
Do not take Cabotres 40 Tablet if you have a known allergy to it or any of its components. Prior to starting Cabotres 40 Tablet, inform your doctor if you have a history of liver or kidney disease, gastrointestinal issues, heart conditions, blood or bleeding disorders, open or healing wounds, or if you have recently undergone surgery. This medication is associated with embryo-fetal toxicity and is therefore not recommended for use during pregnancy or while breastfeeding.
